Skip to content

WeLoveDoctor

  • Contact
  • Intro
Log in

Molecular Testing for Selection of Patients With Lung Cancer for Epidermal Growth Factor Receptor and Anaplastic Lymphoma Kinase Tyrosine Kinase Inhibitors

Written by

byun1114

in

Study

이전에 소개한 논문에서 추가를 해야할 것인가..

뭔 이 사람들은 계속 발표를 하는지…

2013/04/16 – [공부해 봅시다/Pathology] – Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors

Reference: Leighl, N.B., et al., Molecular Testing for Selection of Patients With Lung Cancer for Epidermal Growth Factor Receptor and Anaplastic Lymphoma Kinase Tyrosine Kinase Inhibitors: American Society of Clinical Oncology Endorsement of the College of American Pathologists/International Association for the Study of Lung Cancer/Association for Molecular Pathology Guideline. J Clin Oncol, 2014.

←핑크리본 마라톤 10km
Evaluation of intestinal biopsies for pediatric enteropathy: a proposed immunohistochemical panel approach→

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *

More posts

  • unbound

    2026-11-18
  • 베른트 크라머 “성공의 배신”

    2026-11-17
  • 제프 다이어, 할 그레거슨, 클레이튼 크리스텐슨 “이노베이터 DNA”

    2026-11-16
  • zulip 설치

    2026-11-16
WeLoveDoctor

WeLoveDoctor

  • Activities
  • Andrioid
  • Bike
  • Blender
  • Diarium
  • DICOM
  • Docker
  • Domain
  • Fabula
  • FFmpeg
  • Gnuplot
  • Grafana
  • InfluxDB
  • Investment
  • LaTeX
  • Linux
  • Mikrotik
  • Nginx
  • Node-RED
  • Outdoor
  • Prometheus
  • Python
  • R
  • Rasberry Pi
  • Regulations
  • SQL
  • Study
  • TrueNAS
  • Windows
  • Wordpress

Twenty Twenty-Five

Designed with WordPress